GAVI Alliance partners are spearheading immunization, the health intervention that saves more children than any other. Alliance activities target all the essential links along the immunization supply chain from late-stage research to introduction and delivery.
Harvard economists David Bloom and David Canning looked at the GAVI model and estimated an internal rate of return of more than 12 percent with the potential to top 18 percent by 2020. Read More
"The dispassionate economic case for vaccination looks at least as strong as the compassionate medical one."
— The Economist
Pneumonia and diarrhea kill almost 3 million children under the age of 5 each year. The clock keeps ticking and children in the poorest countries still suffer. Infectious diseases still account for 68% of child mortality.
Proven solutions exist to prevent deaths due to pneumonia and diarrhea in children. There are new vaccines against pneumococcal disease and rotavirus, which are among the main causes of the most severe cases of pneumonia and diarrhea.
The GAVI Alliance has committed to supporting the introduction and wide-scale use of these new vaccines in the world's poorest countries. To achieve this goal, however, GAVI needs to raise an additional US$ 3.7 billion by 2015.